Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-(17'-oxo-5'alpha-androstan-3'alpha-oxy)propanoic acid | 0.003 mM, 48% inhibition | Homo sapiens | |
3alpha,3beta-O-(1'-oxo-1',3'-propanediyloxy)-5alpha-androstan-17-one | 0.003 mM, 53% inhibition | Homo sapiens | |
3alpha-(2'-hydroxypropanoxy)-5alpha-androstan-17-one | 0.003 mM, 89% inhibition | Homo sapiens | |
3alpha-(3'-bromopropanoxy)-5alpha-androstan-17-one | 0.003 mM, 93% inhibition | Homo sapiens | |
3alpha-(3'-hydroxypropanoxy)-5alpha-androstan-17-one | 0.003 mM, 86% inhibition | Homo sapiens | |
3alpha-(prop-2'-enoxy)-5alpha-androstan-17-one | 0.003 mM, 95% inhibition | Homo sapiens | |
3alpha-ethoxy-3beta-(phenylmethyl)-5alpha-androstan-17-one | 0.003 mM, 92% inhibition, IC50: 352 nM | Homo sapiens | |
3alpha-ethoxy-5alpha-androstan-17-one | 0.003 mM, 95% inhibition | Homo sapiens | |
3alpha-hexanoxy-3beta-(phenylmethyl)-5alpha-androstan-17-one | 0.003 mM, 28% inhibition | Homo sapiens | |
3alpha-hexanoxy-5alpha-androstan-17-one | 0.003 mM, 92% inhibition | Homo sapiens | |
3alpha-hydroxy-3'-phenyl-5alpha-androstan-17-one | 0.003 mM, 95% inhibition, IC50: 81 nM | Homo sapiens | |
3alpha-hydroxy-3beta-(3'-hydroxypropyl)-5alpha-androstan-17-one | 0.003 mM, 74% inhibition | Homo sapiens | |
3alpha-hydroxy-3beta-(prop-2'-enyl)-5alpha-androstan-17-one | 0.003 mM, 76% inhibition | Homo sapiens | |
3alpha-hydroxy-3beta-methyl-5alpha-androstan-17-one | 0.003 mM, 93% inhibition | Homo sapiens | |
3alpha-hydroxy-3beta-octyl-5alpha-androstan-17-one | 0.003 mM, 92% inhibition, IC50: 147 nM | Homo sapiens | |
3alpha-hydroxy-3beta-phenylethyl-5alpha-androstan-17-one | 0.003 mM, 93% inhibition, IC50: 99 nM | Homo sapiens | |
3alpha-hydroxy-3beta-phenylmethyl-5alpha-androstan-17-one | 0.003 mM, 94% inhibition, IC50: 57 nM | Homo sapiens | |
3alpha-hydroxy-3beta-phenylpropyl-5alpha-androstan-17-one | 0.003 mM, 97% inhibition | Homo sapiens | |
3alpha-hydroxy-3beta-propyl-5alpha-androstan-17-one | 0.003 mM, 94% inhibition, IC50: 67 nM | Homo sapiens | |
3alpha-hydroxy-3beta-vinyl-5alpha-androstan-17-one | 0.003 mM, 94% inhibition | Homo sapiens | |
3alpha-methoxy-3beta-(2'-phenylethyl)-5alpha-androstan-17-one | 0.003 mM, 95% inhibition, IC50: 73 nM | Homo sapiens | |
3alpha-methoxy-3beta-(phenylmethyl)-5alpha-androstan-17-one | 0.003 mM, 93% inhibition, IC50: 154 nM | Homo sapiens | |
3alpha-methoxy-5alpha-androstan-17-one | 0.003 mM, 94% inhibition | Homo sapiens | |
3alpha-O-(spirotetrahydrofuran-2-yl)-5alpha-androstan-17-one | 0.003 mM, 94% inhibition | Homo sapiens | |
3alpha-propanoxy-3beta-(phenylmethyl)-5alpha-androstan-17-one | 0.003 mM, 87% inhibition | Homo sapiens | |
3alpha-propanoxy-5alpha-androstan-17-one | 0.003 mM, 93% inhibition | Homo sapiens | |
3beta,3alpha-O-(1'-oxo-1',3'-propanediyloxy)-5alpha-androstan-17-one | 0.003 mM, 93% inhibition | Homo sapiens | |
3beta-(2'-cyclohexylethyl)-3alpha-methoxy-5alpha-androstan-17-one | 0.003 mM, 88% inhibition, IC50: 354 nM | Homo sapiens | |
3beta-cyclohexyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 95% inhibition, IC50: 97 nM | Homo sapiens | |
3beta-cyclohexylethyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 93% inhibition, IC50: 60 nM | Homo sapiens | |
3beta-cyclohexylmethyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 95% inhibition, IC50: 87 nM | Homo sapiens | |
3beta-dodecyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 77% inhibition | Homo sapiens | |
3beta-hydroxy-3alpha-(3'-hydroxypropyl)-5alpha-androstan-17-one | 0.003 mM, 17% inhibition | Homo sapiens | |
3beta-hydroxy-3alpha-(prop-2'-enyl)-5alpha-androstan-17-one | 0.003 mM, 36% inhibition | Homo sapiens | |
3beta-hydroxy-3alpha-methyl-5alpha-androstan-17-one | 0.003 mM, 16% inhibition | Homo sapiens | |
3beta-hydroxy-3alpha-phenyl-5alpha-androstan-17-one | 0.003 mM, 39% inhibition | Homo sapiens | |
3beta-hydroxy-3alpha-phenylmethyl-5alpha-androstan-17-one | 0.003 mM, 39% inhibition | Homo sapiens | |
3beta-hydroxy-3alpha-propyl-5alpha-androstan-17-one | 0.003 mM, 33% inhibition | Homo sapiens | |
3beta-n-butyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 92% inhibition, IC50: 116 nM | Homo sapiens | |
3beta-n-hexyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 95% inhibition, IC50: 100 nM | Homo sapiens | |
3beta-s-butyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 90% inhibition, IC50: 73 nM | Homo sapiens | |
3beta-tert-butyl-3alpha-hydroxy-5alpha-androstan-17-one | 0.003 mM, 93% inhibition, IC50: 142 nM | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
androstenedione + NADPH + H+ | Homo sapiens | the enzyme is involved in biosynthesis of testosterone | testosterone + NADP+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
androstenedione + NADPH + H+ | - |
Homo sapiens | testosterone + NADP+ | - |
? | |
androstenedione + NADPH + H+ | the enzyme is involved in biosynthesis of testosterone | Homo sapiens | testosterone + NADP+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
type 3 17beta-hydroxysteroid dehydrogenase | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADPH | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000057 | - |
0.003 mM, 94% inhibition, IC50: 57 nM | Homo sapiens | 3alpha-hydroxy-3beta-phenylmethyl-5alpha-androstan-17-one | |
0.00006 | - |
0.003 mM, 93% inhibition, IC50: 60 nM | Homo sapiens | 3beta-cyclohexylethyl-3alpha-hydroxy-5alpha-androstan-17-one | |
0.000067 | - |
0.003 mM, 94% inhibition, IC50: 67 nM | Homo sapiens | 3alpha-hydroxy-3beta-propyl-5alpha-androstan-17-one | |
0.000073 | - |
0.003 mM, 90% inhibition, IC50: 73 nM | Homo sapiens | 3beta-s-butyl-3alpha-hydroxy-5alpha-androstan-17-one | |
0.000073 | - |
0.003 mM, 95% inhibition, IC50: 73 nM | Homo sapiens | 3alpha-methoxy-3beta-(2'-phenylethyl)-5alpha-androstan-17-one | |
0.000081 | - |
0.003 mM, 95% inhibition, IC50: 81 nM | Homo sapiens | 3alpha-hydroxy-3'-phenyl-5alpha-androstan-17-one | |
0.000087 | - |
0.003 mM, 95% inhibition, IC50: 87 nM | Homo sapiens | 3beta-cyclohexylmethyl-3alpha-hydroxy-5alpha-androstan-17-one | |
0.000097 | - |
0.003 mM, 95% inhibition, IC50: 97 nM | Homo sapiens | 3beta-cyclohexyl-3alpha-hydroxy-5alpha-androstan-17-one | |
0.000099 | - |
0.003 mM, 93% inhibition, IC50: 99 nM | Homo sapiens | 3alpha-hydroxy-3beta-phenylethyl-5alpha-androstan-17-one | |
0.0001 | - |
0.003 mM, 95% inhibition, IC50: 100 nM | Homo sapiens | 3beta-n-hexyl-3alpha-hydroxy-5alpha-androstan-17-one | |
0.000116 | - |
0.003 mM, 92% inhibition, IC50: 116 nM | Homo sapiens | 3beta-n-butyl-3alpha-hydroxy-5alpha-androstan-17-one | |
0.000142 | - |
0.003 mM, 93% inhibition, IC50: 142 nM | Homo sapiens | 3beta-tert-butyl-3alpha-hydroxy-5alpha-androstan-17-one | |
0.000147 | - |
0.003 mM, 92% inhibition, IC50: 147 nM | Homo sapiens | 3alpha-hydroxy-3beta-octyl-5alpha-androstan-17-one | |
0.000154 | - |
0.003 mM, 93% inhibition, IC50: 154 nM | Homo sapiens | 3alpha-methoxy-3beta-(phenylmethyl)-5alpha-androstan-17-one | |
0.000352 | - |
0.003 mM, 92% inhibition, IC50: 352 nM | Homo sapiens | 3alpha-ethoxy-3beta-(phenylmethyl)-5alpha-androstan-17-one | |
0.000354 | - |
0.003 mM, 88% inhibition, IC50: 354 nM | Homo sapiens | 3beta-(2'-cyclohexylethyl)-3alpha-methoxy-5alpha-androstan-17-one |